Deep Health AI India Limited (formerly Deep Diamond India Limited) has submitted its compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter and financial year ended March 31, 2026. The certificate was filed with the Bombay Stock Exchange Limited on April 13, 2026.

Regulatory Compliance Certificate

The company confirmed compliance with dematerialization and rematerialization processes through its registrar and transfer agent, MUFG Intime India Pvt Ltd. The certificate addresses key regulatory requirements for securities handling during the specified period.

Company Information

Deep Health AI India Limited operates from its registered office at 506-509 Fifth floor, Apeksha, plot no. 256, Main Road, Hiran Magri, Sector 11, Udaipur, Rajasthan. The company trades on BSE under scrip code 539559.

RTA Confirmation

MUFG Intime India Private Limited, serving as the company's registrar and transfer agent, provided confirmation on April 1, 2026. The RTA certified that:

• Securities received from depository participants for dematerialization during Q4FY26 were properly confirmed
• All security certificates were listed on relevant stock exchanges
• Physical certificates were mutilated and cancelled after verification
• Depository names were substituted in the member register within prescribed timelines

Regulatory Framework

The certificate submission fulfills mandatory requirements under SEBI (Depositories and Participants) Regulations, 2018. This regulation ensures proper oversight of dematerialization processes and maintains transparency in securities handling by listed companies.

The document was signed by Managing Director Narayan Singh Rathore and copies were provided to National Securities Depository Limited and Central Depository Services (India) Limited, completing the regulatory filing process for Q4FY26.

Deep Health AI India Limited has formally notified BSE Limited about the resignation of Mr. Kailash Chandra from his position as Independent Director, effective from the close of business hours on April 03, 2026. The announcement was made in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Director Resignation Details

The resignation was communicated through an official letter dated April 03, 2026, addressed to BSE Limited. The company provided comprehensive details as required under regulatory guidelines, including annexures containing the resignation letter and detailed information about the departing director.

Board Committee Memberships

Mr. Kailash Chandra held significant responsibilities within the company's governance structure. His committee memberships included key oversight roles that are essential for corporate governance and regulatory compliance.

Regulatory Compliance

The company has fulfilled all regulatory requirements associated with the director's resignation. In his resignation letter, Mr. Kailash Chandra confirmed that there were no material reasons for his departure other than personal circumstances. The director was associated solely with Deep Health AI India Limited and did not hold directorship positions in any other listed entities.

The resignation letter was submitted with proper acknowledgment and digital signature verification. The filing was made pursuant to SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated January 30, 2026, ensuring complete regulatory compliance.

Company Background

Deep Health AI India Limited, formerly known as Deep Diamond India Limited, operates from its registered office in Udaipur, Rajasthan. The company's Managing Director, Mr. Narayan Singh Rathore (DIN: 10900646), signed the regulatory filing that was submitted to the stock exchange.

The resignation represents a change in the company's board composition, with the departure of an independent director who served on multiple key committees responsible for audit oversight, executive compensation, and stakeholder relations.